组织谷氨酰胺转胺酶
纤维连接蛋白
粘附
细胞粘附
细胞生物学
化学
卵巢癌
细胞
癌症研究
癌症
生物化学
生物
酶
遗传学
有机化学
作者
Ning Yang,Ali Abbaspour,James M. Considine,Stephanie M. McGregor,Erin G. Brooks,Alexandra Naba,Kristyn S. Masters,Pamela K. Kreeger
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2025-05-16
被引量:1
标识
DOI:10.1101/2025.05.13.653765
摘要
Abstract The extracellular matrix (ECM) plays a crucial role in tumor progression. Here, we analyzed collagen I and cellular fibronectin (cFN) in normal omentum and metastatic omentum from high-grade serous ovarian cancer ( HGSOC). The levels of both proteins were significantly elevated and collagen I fibers were significantly thicker in HGSOC metastases. Moreover, the ECM cross-linking enzyme transglutaminase 2 (TG2) was increased in omental metastases, where it is enzymatically active in the extracellular environment. This information was used to develop ECM constructs recapitulating these key changes, alone and in combination, to investigate their impact on HGSOC cell adhesion. To our knowledge, this is the first report using TG2 as a cross-linking agent to generate constructs from multiple ECM components. Low levels of HGSOC cell adhesion were observed on colIagen-only (coll) gels, while inclusion of cFN or plasma fibronection (pFN) increased cell adhesion. TG2-mediated cross-linking of colI/cFN hydrogels promoted HGSOC cell adhesion, while cross-linking of coll/pFN had no effect. Cell adhesion was dependent on ligand identity and fiber diameter. When fiber thickness was held constant, the inclusion of cFN led to greater HGSOC cell adhesion relative to pFN or coll, due to interactions of β1 integrins with the EDA and RGD domains of cFN. Meanwhile, when gel composition was held constant, HGSOC cell adhesion increased as fiber thickness was increased through modifications to gelation temperature. Combined, our results demonstrate how ECM changes associated with omental metastasis can support tumor progression and provide insights into methods to tailor biomaterials to support cell adhesion.
科研通智能强力驱动
Strongly Powered by AbleSci AI